New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 3, 2014
11:20 EDTVNDAVanda shares attractive amid negative sentiment, says Piper Jaffray
Piper Jaffray believes the negative sentiment surrounding shares of Vanda Pharmaceuticals presents an excellent entry point into the name. Piper says Vanda has yet to ramp its physician education efforts regarding Hetlioz and that the dug has the potential to be a multi-hundred million dollar product. The firm reiterates an Overweight rating on Vanda with a $21 price target.
News For VNDA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 25, 2015
10:37 EDTVNDAOptions with decreasing implied volatility
Options with decreasing implied volatility: FUEL GREK NLNK HLSS SLXP LL VNDA AWAY DWA TRUE
February 24, 2015
10:08 EDTVNDAOptions with decreasing implied volatility
Subscribe for More Information
February 23, 2015
10:17 EDTVNDAOptions with decreasing implied volatility
Subscribe for More Information
February 19, 2015
09:12 EDTVNDAOn The Fly: Pre-market Movers
Subscribe for More Information
07:09 EDTVNDAVanda sees FY15 sales of Hetlioz and Fanapt $95M-$110M
Subscribe for More Information
07:08 EDTVNDAVanda reports Q4 adjusted EPS (36c), two estimates (20c)
Reports Q4 revenue $15.37M, two estimates $16.15M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use